FDA Finds at Least 19 Cases of Skin Cancer in Breast Implant Data, including 3 Deaths

Though the FDA has long been aware of the risk that some people with breast implants may develop a rare form of T-cell lymphoma—now known as breast implant-associated anaplastic large cell lymphoma and tracked by the regulator since 2011—the agency has only recently begun warning about other cancer risks linked to the implants.